Liz Meeks

Liz Meeks is a Senior Managing Director in Investment Banking at Leerink Partners, specializing in the biopharma sector.

Prior to joining the Firm in 2018, Ms. Meeks was a member of the Biopharma Investment Banking team at Piper Sandler. Earlier, she served as Manager of Corporate Development at Hyperion Therapeutics, which was acquired by Horizon Pharma in 2015. She has more than a decade of experience advising biopharma companies on capital markets, mergers and acquisitions, and strategic transactions.

Ms. Meeks earned a B.S. from Haverford College and an MBA from INSEAD.